This article is more than 5 years old. Information may no longer be current.

InVivo Therapeutics receives Notice of Allowance for patent covering new scaffold system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

InVivo Therapeutics recently announced it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent titled “Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries,” according to a press release.

This patent, No. 14/496,742, covers the company’s Neuro-Spinal Scaffold, which is currently being studied in a pilot clinical trial and has been successfully implanted in three patients, and the Neuro-Spinal Scaffold Plus Stem Cells program, which is being developed for the treatment of chronic spinal cord injuries.

The scaffold is surgically implanted at the epicenter of the wound after an acute spinal cord injury and acts as a physical substrate for nerve sprouting, according to the release. It has received a Humanitarian Use Device (HUD) designation is being studied in an Investigational Device Exemption (IDE) pilot study for patients with traumatic acute spinal cord injuries, according to the release.

Reference: www.invivotherapeutics.com